InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

MiNK Therapeutics, Inc.

INKT Clue Score16
United States Fiscal year ends December CIK 0001840229 Results filed 13 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

17
Insider
Date
Role
Action
Shares
Price
Amount
Agenus Inc
16 Oct 2023
10% owner
Buy
429
$1.10
$471.56
Agenus Inc
13 Oct 2023
10% owner
Buy
19,373
$1.10
$21.31K
Agenus Inc
12 Oct 2023
10% owner
Buy
3,173
$1.10
$3.49K
Agenus Inc
4 Oct 2023
10% owner
Buy
15,001
$1.09
$16.38K
Agenus Inc
29 Aug 2023
10% owner
Buy
29,678
$1.52
$45.02K
Agenus Inc
28 Aug 2023
10% owner
Buy
12,808
$1.45
$18.57K
Agenus Inc
24 Aug 2023
10% owner
Buy
170,244
$1.54
$262.91K
Agenus Inc
11 May 2023
10% owner
Buy
23,361
$1.43
$33.35K
Agenus Inc
10 May 2023
10% owner
Buy
22,065
$1.51
$33.30K
Agenus Inc
5 May 2023
10% owner
Buy
200
$1.25
$250.00
Agenus Inc
5 May 2023
10% owner
Buy
100,000
$0.95
$94.85K
Agenus Inc
4 May 2023
10% owner
Buy
21,473
$1.22
$26.25K
Agenus Inc
3 May 2023
10% owner
Buy
128,689
$1.08
$138.84K
Garo H Armen
2 May 2023
Director
Buy
100,000
$0.95
$94.85K
Ulf Wiinberg
19 Jul 2022
Director
Buy
16,661
$1.39
$23.21K
Ulf Wiinberg
18 Jul 2022
Director
Buy
3,339
$1.33
$4.44K
Agenus Inc
19 Oct 2021
10% owner
Buy
1,400,000
$12.00
$16.80M
Show all 27 transactions →

What was left out

Form 4 filings counted 125
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 10
Transactions with no price 0
Shares from compensation/vesting 12,966,743
History held since 20 Oct 2021